INDIA PHARMA CARE

India’s Healthcare Sector – Advantage India

India is the 7th largest country by area & the second most populous country in the world. Healthcare has become one of India's largest growing sectors, both in terms of revenue & employment.

The hospital industry is forecasted to increase to US$ 132.84 billion by FY22 from US$ 61.79 billion in FY17 at a CAGR of 16%. The total industry size is estimated to reach US$ 372 billion by 2022.

India is the largest provider of generic medicines globally, occupying a 20% share in global supply by volume, US$ 40 billion by value. Also supplies a staggering 62% of global demand for vaccine. Ambition to achieve US$ 130 billion by 2030 at a CAGR of ~12% from 2020 to 2030.

Demand growth, cost advantages & policy support have been instrumental in attracting Foreign Direct Investment (FDI). Between Apr 2000 & Dec 2020, FDI inflows for drugs & pharmaceuticals sector stood at US$ 17.74 billion. Inflows in sectors such as hospitals & diagnostic centres, medical & surgical appliances stood at US$ 7.03 billion & US$ 2.17 billion, respectively.